Organization
St Pharm
2 clinical trials
Clinical trial
First-In-Human Dose-Escalation Study of STP1002 in Patients With Advanced-Stage Solid TumorsStatus: Completed, Estimated PCD: 2023-03-10
Clinical trial
A Phase 2a, Randomized, Double-Blinded, Placebo-Controlled, Multicenter Study to Investigate the Antiviral Effect, Safety, Tolerability, and Pharmacokinetics of STP0404 in Treatment-Naïve Adults With HIV-1 InfectionStatus: Recruiting, Estimated PCD: 2024-10-21